Free Trial
→ Trump Orders 'National Digital Asset Stockpile' (From Crypto 101 Media) (Ad) Buy RDHL Stock  Free RDHL Stock Alerts

RedHill Biopharma (RDHL) SEC Filings & 10K Form

RedHill Biopharma logo
$2.26 +0.19 (+9.18%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$2.24 -0.02 (-0.88%)
As of 04/17/2025 06:22 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent RedHill Biopharma SEC Filings

Export to Excel
DateFilerForm TypeView
04/17/2025
3:06 PM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/16/2025
6:02 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/10/2025
6:51 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/10/2025
6:36 AM		RedHill Biopharma (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
04/08/2025
6:00 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/26/2025
6:00 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/18/2025
6:02 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/12/2025
6:01 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/27/2025
6:01 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/25/2025
6:04 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/04/2025
6:04 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/03/2025
3:28 PM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/03/2025
3:05 PM		RedHill Biopharma (Filer)
Form 424B5
01/21/2025
6:05 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/10/2024
6:03 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/02/2024
6:03 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/14/2024
11:22 AM		CVI Investments, Inc. (Filed by)
RedHill Biopharma (Subject)
Form SC 13G/A
10/28/2024
6:01 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/22/2024
6:01 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/15/2024
5:02 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/01/2024
6:02 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/30/2024
6:01 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/18/2024
8:00 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/17/2024
8:13 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2024
6:04 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2024
7:30 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2024
6:05 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/03/2024
6:03 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/29/2024
6:07 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/26/2024
6:02 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/21/2024
6:04 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/19/2024
11:15 PM		RedHill Biopharma (Filer)
Form EFFECT
08/19/2024
6:01 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/16/2024
6:13 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/13/2024
12:37 PM		RedHill Biopharma (Filer)
Form 424B3
08/13/2024
7:35 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/09/2024
6:01 AM		RedHill Biopharma (Filer)
Form F-3
Registration statement for securities of certain foreign private issuers  
08/07/2024
3:43 PM		Quintairos, Prieto, Wood & Boyer P.A. (Filed by)
RedHill Biopharma (Subject)
Form SCHEDULE 13D
08/07/2024
8:51 AM		RedHill Biopharma (Filer)
Form 424B3
08/06/2024
6:00 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/01/2024
6:05 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
100-year-old investment secret predicts what?! (Ad)

A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust, the 2008 crisis, and the crash of 2020. Now, it’s flashing again. Eliza Lasky of Weiss Advocate reveals what this forgotten signal says about the next big move — and how smart investors are preparing.

This 100-year-old signal is flashing again — find out what it predicts
07/22/2024
6:04 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/09/2024
7:03 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2024
6:23 AM		RedHill Biopharma (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/06/2024
8:00 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/03/2024
6:04 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/06/2024
6:01 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2024
6:05 AM		RedHill Biopharma (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/22/2024
11:15 PM		RedHill Biopharma (Filer)
Form EFFECT
04/18/2024
6:00 AM		RedHill Biopharma (Filer)
Form POS AM
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:RDHL) was last updated on 4/18/2025 by MarketBeat.com Staff
From Our Partners
Trump’s Secret Weapon
Have you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...
American Alternative | Sponsored
Elon Reveals Why There Soon Won’t Be Any Money For Social Security
Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...
Colonial Metals | Sponsored
Trump’s Bitcoin Reserve is No Accident…
Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...
Crypto 101 Media | Sponsored
100-year-old investment secret predicts what?!
A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...
Weiss Ratings | Sponsored
The first casualty of the 2025 trade war
The headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...
Investors Alley | Sponsored
How War with China Could Start in 128 Days
The clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...
Behind the Markets | Sponsored
My prediction is coming true
We've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...
InvestorPlace | Sponsored
🥾⛏️👷‍♂️ What I Learned From Numerous Mine Visits...
Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...
Golden Portfolio | Sponsored